TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

InspireMD Reports Third Quarter 2025 Financial Results

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Inspiremd, Inc.
InspireMD Reports Third Quarter 2025 Financial Results

InspireMD reported Q3 2025 financial results, highlighting a 39% revenue increase to $2.5 million, successful U.S. commercial launch of CGuard Prime carotid stent system, and continued global market expansion despite increased operating expenses.

Insights
NSPR   neutral

Mixed financial performance with revenue growth but increased operating expenses and continued net loss. Positive signs include successful U.S. market entry and strong global demand, balanced by ongoing financial challenges.